Viridian Therapeutics Inc. (VRDN)
Market Open
2 Sep, 18:05
$
22. 61
-0.43
-1.8454%
$
2.61B Market Cap
- P/E Ratio
- Div Yield
636,124 Volume
-4.96 Eps
$ 23.03
Previous Close 
Want to track VRDN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viridian Therapeutics Inc. (VRDN) Statistics
Valuation metrics
Market Cap 2.61B
Enterprise value 2.69B
Trailing P/E (ttm) -6.54
Forward P/E -5.5
PEG ratio -0.73
Price/Sales (ttm) 36.76
Price/Book (mrq) 3.76
Enterprise Value/Revenue 37.86
Enterprise Value/EBITDA -7.32
Overview
Shares outstanding 101.83M
Float 102.15M
Shares short 10.66M
% Held by insiders 0%
% Held by institutions 1.07%
Average volume (10 days) 778.88K
Average volume (90 days) 1.94M
Price summary
52-Week low 13.18
52-Week high 34.29
Beta 1.17
50-Day moving average 22.34
200-Day moving average 21.26
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 13 Nov 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -5.44%
Operating margin -5.7%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.61%
Income Statement
Revenue (ttm) 70.85M
Revenue per share (ttm) 0.66
Quarterly revenue growth (yoy) 0.83%
Gross profit (ttm) -268.08M
EBITDA -362.94M
Net income to common (ttm) -281.93M
Diluted EPS (ttm) -3.59
Quarterly earnings growth (yoy) 0.83%
Balance Sheet
Total cash (mrq) 874.65M
Total cash per share (mrq) 9.1
Total debt (mrq) 52.59M
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 16.95%
Book value per share (mrq) 6.14
Cash Flow
Cash flow statement -276.39M
Levered free cash flow (LFCF) -162.07M
